The survival rate of HNSCC patients with high PD-1 expression in the low risk group was lower than that in the other groups, while high PD-1 expression in the high risk group was beneficial to improve the survival rate of HNSCC patients (p < 0.001). The gene discussed is PDCD1; the disease is head and neck squamous cell carcinoma.